Health
Heart Transplant ‘Liquid Biopsy’; PCSK9 CRISPR; More SGLT2 Drugs Try FDA in HF – MedPage Today
Recent developments of interest in cardiovascular medicine
A blood test showed promise as a “liquid biopsy” for detection of acute heart transplant rejection. (Circulation)
Early efforts to use CRISPR to edit PCSK9 genes in severe heterozygous familial hypercholesterolemia are moving forward. (Endpoints News)
In a study of 145 student athletes with no more than moderate COVID-19 symptoms, cardiac MRI a median 15 days after the positive test was consistent with myocarditis in two (1.4%). (JAMA Cardiology)
Each extra serving of fried foods per week was linked…
-
Business15 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General21 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Noosa News14 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News11 hours agoTips to improve engagement – Proctor